Ambient carbon monoxide and the risk of hospitalization due to chronic obstructive pulmonary disease

American Journal of Epidemiology

Volumn 180, Issue 12, 2014, Pages 1159-1167

  Tian, Linwei ^a   Ho, Kin Fai ^a   Wang, Tong ^a   Qiu, Hong ^a   Pun, Vivian C ^a   Chan, Chi Sing ^a   Louie, Peter K K ^a   Yu, Ignatius T S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Carbon monoxide; Chronic obstructive pulmonary disease; Time series study

Indexed keywords

CARBON MONOXIDE; NITROGEN DIOXIDE; AIR POLLUTANT; PARTICULATE MATTER;

ATMOSPHERIC POLLUTION; CARBON MONOXIDE; CONCENTRATION (COMPOSITION); DATA SET; HOSPITAL SECTOR; NITROGEN DIOXIDE; NUMERICAL MODEL; POLLUTION EXPOSURE; RESPIRATORY DISEASE; RISK FACTOR; TIME SERIES ANALYSIS;

AGED; AMBIENT AIR; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; HONG KONG; HOSPITALIZATION; HUMAN; MALE; PARTICLE SIZE; PARTICULATE MATTER; RISK ASSESSMENT; TIME SERIES ANALYSIS; VERY ELDERLY; AIR POLLUTANT; AIR POLLUTION; ANALYSIS; EMERGENCY HEALTH SERVICE; PATHOPHYSIOLOGY; POISSON DISTRIBUTION; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME; WEATHER;

CHINA; HONG KONG;

AIR POLLUTANTS; AIR POLLUTION; CARBON MONOXIDE; EMERGENCY SERVICE, HOSPITAL; ENVIRONMENTAL EXPOSURE; FEMALE; HONG KONG; HOSPITALIZATION; HUMANS; MALE; NITROGEN DIOXIDE; PARTICULATE MATTER; POISSON DISTRIBUTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TIME FACTORS; WEATHER;

EID: 84922381468     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu248     Document Type: Article

References (33)

1. WorldHealthOrganization.Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: a Comprehensive Approach. Geneva, Switzerland: World Health Organization; 2007. http://whqlibdoc.who.int/publications/2007/ 9789241563468-eng.pdf?ua=1. Accessed August 12, 2014.
2. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589): 786-796.
3. Reilly JJ, Silverman EK, Shapiro SD. Chapter 18 Chronic obstructive pulmonary disease. In: Loscalzo J, ed. Harrison's Pulmonary and Critical Care Medicine. New York, NY: The McGraw-Hill Companies, Inc.; 2010:178-189.
4. Anderson HR, Spix C, Medina S, et al. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J. 1997;10(5):1064-1071.
5. Ko FW, Tam W, Wong TW, et al. Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong. Thorax. 2007; 62(9):780-785.
6. Medina-Ramón M, Zanobetti A, Schwartz J. The effect of ozone and PM10 on hospital admissions for pneumonia and chronic obstructive pulmonary disease: a national multicity study. Am J Epidemiol. 2006;163(6):579-588.
7. Moolgavkar SH. Air Pollution and Daily Deaths and Hospital Admissions in Los Angeles and Cook Counties. Boston, MA: Report of Health Effects Institute; 2003.
8. Slaughter JC, Kim E, Sheppard L, et al. Association between particulate matter and emergency room visits, hospital admissions and mortality in Spokane,Washington. J Expo Anal Environ Epidemiol. 2005;15(2):153-159.
9. Yang Q, Chen Y, Krewski D, et al. Effect of short-term exposure to low levels of gaseous pollutants on chronic obstructive pulmonary disease hospitalizations. Environ Res. 2005;99(1):99-105.
10. US Environmental Protection Agency. Integrated Science Assessment for Carbon Monoxide (Full Report). Washington, DC: United States Environmental Protection Agency; 2010. http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=218686. Published January 29, 2010. Accessed July 16, 2014.
11. Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov. 2010;9(9): 728-743.
12. Ryter SW, Choi AM. Heme oxygenase-1/carbon monoxide: novel therapeutic strategies in critical care medicine. Curr Drug Targets. 2010;11(12):1485-1494.
13. Bathoorn E, Slebos DJ, Postma DS, et al. Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J. 2007;30(6):1131-1137.
14. Wong TW, Lau TS, Yu TS, et al. Air pollution and hospital admissions for respiratory and cardiovascular diseases in Hong Kong. Occup Environ Med. 1999;56(10):679-683.
15. Ito K, Thurston GD, Silverman RA. Characterization of PM2.5, gaseous pollutants, and meteorological interactions in the context of time-series health effects models. J Expo Sci Environ Epidemiol. 2007;17(Suppl 2):S45-S60.
16. Zhou J, Ito K, Lall R, et al. Time-series analysis of mortality effects of fine particulate matter components in Detroit and Seattle. Environ Health Perspect. 2011;119(4):461-466.
17. Barnett AG, Williams GM, Schwartz J, et al. Air pollution and child respiratory health: a case-crossover study in Australia and New Zealand. Am J Respir Crit Care Med. 2005;171(11): 1272-1278.
18. Wong CM, Vichit-Vadakan N, Kan H, et al. Public Health and Air Pollution in Asia (PAPA): a multicity study of short-term effects of air pollution on mortality. Environ Health Perspect. 2008;116(9):1195-1202.
19. Gasparrini A. Distributed lag linear and non-linear models in R: the package dlnm. J Stat Softw. 2011;43(8):1-20.
20. R Development Core Team. R: A Language and Environment for Statistical Computing. 2013. http://web.mit.edu/r-v3.0.1/ fullrefman.pdf. Published May 16, 2013. Accessed July 16, 2014.
21. Wood SN. Generalized Additive Models: An Introduction with R. New York, NY: Chapman &Hall/CRC, Taylor &Francis Group; 2006.
22. Peel JL, Tolbert PE, Klein M, et al. Ambient air pollution and respiratory emergency department visits. Epidemiology. 2005; 16(2):164-174.
23. Tolbert PE, Klein M, Peel JL, et al. Multipollutant modeling issues in a study of ambient air quality and emergency department visits in Atlanta. J Expo Sci Environ Epidemiol. 2007;17(Suppl 2):S29-S35.
24. Sint T, Donohue JF, Ghio AJ. Ambient air pollution particles and the acute exacerbation of chronic obstructive pulmonary disease. Inhal Toxicol. 2008;20(1):25-29.
25. Qiu H, Yu IT, Tian L, et al. Effects of coarse particulate matter on emergency hospital admissions for respiratory diseases: a time-series analysis in Hong Kong. Environ Health Perspect. 2012;120(4):572-576.
26. WegielB,HantoDW,OtterbeinLE.The social networkof carbon monoxide in medicine. Trends Mol Med. 2013;19(1):3-11.
27. Chin BY, Otterbein LE. Carbon monoxide is a poison. . to microbes! CO as a bactericidal molecule. Curr Opin Pharmacol. 2009;9(4):490-500.
28. Nobre LS, Seixas JD, Roma&tild;o CC, et al. Antimicrobial action of carbon monoxide-releasing compounds. Antimicrob Agents Chemother. 2007;51(12):4303-4307.
29. Wilson JL, Jesse HE, Poole RK, et al. Antibacterial effects of carbon monoxide. Curr Pharm Biotechnol. 2012;13(6):760-768.
30. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6(4):422-428.
31. Tian L, Qiu H, Pun VC, et al. Ambient carbon monoxide associated with reduced risk of hospital admissions for respiratory tract infections. Am J Respir Crit Care Med. 2013; 188(10):1240-1245.
32. Sarady JK, Zuckerbraun BS, Bilban M, et al. Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. FASEB J. 2004;18(7):854-856.
33. Thom SR, Fisher D, Xu YA, et al. Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci U S A. 2000;97(3):1305-1310.